Nutex Health Inc (NUTX) News & EventsNUTXNutex Health Inc

Nutex Health Reports Q1 Revenue of $216.49M

Reports Q1 revenue $216.49M, consensus $227.8M. "The 2026 year has started out strong producing solid revenue of $216.5 million, net income attributable to Nutex of $46.8 million, diluted EPS of $6.52 per share and $75.5 million of operating cash flow in the quarter. Our balance sheet remains very strong with a record high cash balance of $207.3 million. We are well positioned for our planned growth of three new hospital openings later this year," stated Jon Bates, CFO of Nutex Health.

Oil Prices Surge as Markets Decline Due to Geopolitical Risks

Futures are lower this morning with investors continuing to price the macro and geopolitical shock stemming from the rapidly escalating conflict involving Iran and its implications for global energy supply along with a U.S. jobs report released for February that came in much weaker than expected. Approximately 92,000 jobs were lost in February, while the unemployment rate ticked up slightly to 4.4%.The dominant driver of markets right now is oil and energy risk. The conflict threatens shipping routes in the Persian Gulf and the Strait of Hormuz, a chokepoint for global crude flows. Oil prices have surged sharply this week, creating renewed fears that the world could face another inflation shock just as central banks were hoping inflation would moderate.Despite the geopolitical stress, markets are not collapsing outright. Equities and crypto have stabilized somewhat after an early-week selloff, suggesting investors still believe the conflict may remain geographically contained or resolved relatively quickly. However, the bond market is signaling more skepticism, with yields and inflation expectations moving in ways that suggest investors are bracing for prolonged volatility.In pre-market trading, S&P 500 futures fell 0.99%, Nasdaq futures fell 1.23% and Dow futures fell 0.95%.Check out this morning's top movers from around Wall Street, compiled by The Fly.UP AFTER EARNINGS -Genescoup 19%Marvellup 10%MarketWiseup 2%Guidewireup 2%DOWN AFTER EARNINGS -Nutex Healthdown 23%Owletdown 22%Gapdown 9%Embraerdown 2%Algonquin Powerdown 1%LOWER -Western Allianceand Jefferiesdown 7% and 5%, respectively, after Jefferies said that payments of $126.4M owed to Western Alliance Bank pursuant to a forbearance agreement will not be paid as agreed

Nutex Health Reports $11.8M Net Income for Q4 2025

Net income attributable to Nutex Health for the three months ended December 31, 2025 was $11.8M as compared to net income attributable to Nutex Health of $61.6M for the same period in 2024. The company attributes the $105.9M revenue decrease primarily to two items: a one-time $55.0M cumulative true-up of arbitration claims determined ineligible , with the associated catch-up reduced the number of active disputes compared to the same period in 2024 and contributed to lower net revenue for the quarter; and arbitration revenues of $69.0M relating to submissions during 3Q24 that were recorded in 4Q24. After considering the impact of the adjustments above, 4Q25 revenue would be $206.7M and 4Q24 revenue would be $188.6M, a revenue increase of $18.1M. "We are continuing to add to a record year with 82% revenue growth, Adjusted EBITDA attributable to Nutex Health of $259.6M, a 126.4% increase in gross profit and a record high cash balance of $185.6M," stated CFO Jon Bates. "Compared to 2024, we delivered improvements across nearly all key financial metrics. During 2025 and early 2026, we successfully opened three new micro-hospitals, further expanding our national footprint. In addition, both ER visits and inpatient admissions grew year over year, reflecting increased demand and strengthened operational performance," stated CEO Tom Vo. "Looking ahead, we are well positioned for continued growth through a balanced strategy that includes both de novo hospital development and increased patient volumes across our existing facilities."